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London, United Kingdom; and d School of Women's & Children's Health, University of New South Wales, Randwick, New
South Wales, AustraliaObjective: To investigate functionally important transcripts in single human oocytes with the use of NanoString technology and deter-
mine whether observed differences are biologically meaningful.
Design: Analysis of human oocytes with the use of NanoString and immunoblotting.
Setting: University-afﬁliated reproductive medicine unit.
Patients: Women undergoing in vitro fertilization.
Intervention: Human oocytes were analyzed with the use of NanoString or immunoblotting.
Main Outcome Measures: The abundance of transcripts for ten functionally important genes—AURKA, AURKC, BUB1, BUB1B
(encoding BubR1), CDK1, CHEK1, FYN, MOS, MAP2K1, and WEE2—and six functionally dispensable genes were analyzed with the
use of NanoString. BubR1 protein levels in oocytes from younger and older women were compared with the use of immunoblotting.
Result(s): All ten functional genes but none of the six dispensable genes were detectable with the use of NanoString in single oocytes.
There was 3- to 5-fold variation in BUB1, BUB1B, and CDK1 transcript abundance among individual oocytes from a single patient.
Transcripts for these three genes—all players within the spindle assembly checkpoint surveillance mechanism for preventing
aneuploidy—were reduced in the same oocyte from an older patient. Mean BUB1B transcripts were reduced by 1.5-fold with aging
and associated with marked reductions in BubR1 protein levels.
Conclusion(s): The abundance of functionally important transcripts exhibit marked oocyte-to-oocyte heterogeneity to a degree that isUse your smartphonesufﬁcient to affect protein expression. Observed variations in transcript abundance are therefore
likely to be biologically meaningful, especially if multiple genes within the same pathway are
simultaneously affected. (Fertil Steril 2014;101:857–64. 2014 by American Society for
Reproductive Medicine.)
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stems from the extreme paucity of
human oocytes available for research,
making approaches capable of single-
oocyte analysis especially appealing.
Many studies have now examined
gene expressionat themRNA level inhu-
man oocytes (1–5). Moreover, by
incorporating an ampliﬁcation stage,
analyses have been extended to single
human oocytes (6, 7) and even single
polar bodies (8). Notably, however, the857
ORIGINAL ARTICLE: REPRODUCTIVE SCIENCEfunctions of the overwhelming majority of genes reported in
those studies have not previously been examined speciﬁcally
in oocytes but are instead inferred from their roles in mitotic
(somatic) cells. Furthermore, it is not known whether the
differences observed in mRNA abundance between distinct
groups of patients, such as older versus younger, have any
meaningful impact on protein abundance, the downstream
mediator of gene function. Nor has it been explored how
deregulated transcripts within the same oocyte might relate to
one another, for example, by acting within a common
regulatory pathway.
The NanoString nCounter system is a new technology for
digitally estimating mRNA abundance with the use of unique
color-coded probes (9). NanoString is more sensitive than
microarrays and of similar sensitivity to qPCR (9) and is
now used to validate microarrays (10) and next-generation
sequencing technology (11). NanoString has not previously
been applied to human oocytes.
Herein, we used NanoString technology to analyze
functionally important genes in single human oocytes. We
identify striking ‘‘in-patient’’ oocyte-to-oocyte heterogeneity
in key genes. Moreover, the extent of variation observed for
one such gene, BUB1B, is associated with marked reductions
in total oocyte levels of the encoded BubR1 protein. Interest-
ingly, transcripts for BUB1 and CDK1 were also found to be
reduced along with BUB1B within the same oocyte. Given
that all three genes are pivotal players within the spindle
assembly checkpoint (SAC) signaling pathway for ensuring
accurate chromosome segregation, the potential disruptive
consequences could be exponentially greater.MATERIALS AND METHODS
Source of Human Oocytes and Ethical Approval
Human oocytes were obtained from women undergoing
in vitro fertilization (IVF; with or without intracytoplasmic
sperm injection) at the IVF Unit at University College London
Hospitals. Written patient consent was obtained after ethical
approval was received from the National Research Ethics Ser-
vice Committee London (REC reference 11/LO/1360). All
women were <40 years old, had a body mass index (BMI)
<30 kg/m2, were nonsmokers, and met eligibility criteria
for National Health Service–funded treatment. Procedures
used for IVF have been described previously (12).
Oocytes used for nCounter analyses were obtained from
14 women (age-range 30–39 years). Oocytes for immunoblot-
ting were obtained from 12 women, ﬁve who were <32 years
(‘‘young’’) and seven who were >37 years (‘‘older’’).Human Oocyte Samples
Two nCounter assays involving a total of 39 oocytes were
undertaken. Each assay has the capacity for simultaneously
analyzing 12 samples.
One assay analyzed triplicate samples of ﬁve and three
pooled human oocytes at the metaphase II (MII)–arrested
stage (5- and 3-oocyte samples), quadruplicate samples of
single MII-stage oocytes (single-oocyte samples) and dupli-
cate samples of single oocytes at the germinal vesicle (or858GV) stage (Supplemental Table 1; Supplemental Tables 1-3
are available online at www.fertstert.org). Two of the 5-
oocyte samples were derived from one patient each, whereas
the third sample was composed of oocytes pooled from two
patients. The 3-oocyte samples were derived from one patient
each. Two of the single-oocyte samples were from the same
patient, whereas the other two were from two different pa-
tients. Both GV-stage oocytes were from the same patient.
The other NanoString assay included triplicate single-
oocyte samples from each of two patients, triplicate samples
in which no oocytes were added but were of otherwise
identical volume and chemical composition (termed ‘‘empty’’
samples), and three oocytes from a single patient that were
lysed together in one larger-volume sample before being
divided into three equal volumes (termed ‘‘one-third’’
samples) (Supplemental Table 2; Supplemental Tables 1–3
are available online at www.fertstert.org). These one-third
samples function as an indicator of any potential assay to
assay variability, which is not normalized away by the
positive control normalization (see later); differences in
results likely reﬂect sample pipetting inaccuracies.
Oocytes used for immunoblotting were all at the MII stage.
GV-stage oocytes were obtained40 h after hCG admin-
istration. MII-stage oocytes comprised failed-to-fertilize
oocytes, the determination of which was made 18–20 h after
insemination. Cumulus-free oocytes were washed free of
culture medium with the use of 1% polyvinyl pyrolidone
(Sigma) and lysed either in RLT buffer (Qiagen) to make a ﬁnal
sample volume of 5 mL for NanoString analyses or in LDS
sample buffer (Nupage; Invitrogen) in pools of ten for immu-
noblotting. Lysates were snap-frozen at 80C.NanoString nCounter Analyses
The nCounter assay (NanoString Technologies) involves
hybridizing target sequences in the sample by complemen-
tary base pairing to a pair of gene-speciﬁc probes. Each
probe pair is composed of a reporter probe (bearing a
unique color barcode derived from a speciﬁc conﬁguration
of four possible colours at six positions) and a biotinylated
capture probe so that hybridization results in the production
of tripartite probe-target complexes in solution. We used an
off-the-shelf Codeset, the nCounter GX Human Kinase
Panel (NanoString Technologies), containing probe pairs
directed against 528 human kinase-encoding genes and 8
reference genes (identiﬁed by bold italics in Supplemental
Tables 1 and 2). Hybridizations were carried out according
to the NanoString Gene Expression Assay manual. Each
5-mL oocyte sample in RLT buffer was mixed directly with
10 mL nCounter reporter probes, 5 mL nCounter capture
probes, and 10 mL hybridization buffer for a total reaction
volume of 30 mL. The hybridizations were incubated at
65C for 16–20 h.
Following hybridization, a custom liquid-handling
robot, the nCounter Prep Station, was used to remove
excess probes by afﬁnity puriﬁcation. The tripartite com-
plexes were then bound via their biotinylated capture
probes to the streptavidin-coated surface of a sample car-
tridge, electrophoresed to elongate and align the complexes,VOL. 101 NO. 3 / MARCH 2014
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end-product at this stage is a series of immobilized mRNA
transcripts derived from the sample, each tagged with a
speciﬁc color barcode corresponding to a particular gene
transcript. Subsequently, the cartridges were placed in the
nCounter Digital Analyzer for fully automated imaging
and data collection. The expression level of a gene was
determined by counting the number of times its speciﬁc
barcode was detected.
Positive control normalized nCounter data are normal-
ized to the average of the counts of a titrated series of six
synthetic RNA transcripts that are spiked into every hybrid-
ization reaction. Normalization to these internal positive
control samples, which are provided with the assay reagents,
account for slight differences in assay efﬁciency (hybridiza-
tion, puriﬁcation, binding, etc.). Concentrations of the con-
trol transcripts range from 0.125 fM to 128 fM. In a typical
nCounter assay, a second normalization to the expression of
appropriate reference (or ‘‘housekeeping’’) genes to control
for sample input can also be performed. We focused our an-
alyses on positive control normalized data because we added
deﬁned numbers of oocytes directly to the assay without
RNA puriﬁcation, thereby reducing the likelihood of any
meaningful variation in sample input. Positive control
normalized data from both assays are presented for all genes
in the GX Human Kinase Panel in Supplemental Tables 1
and 2. As described in greater detail later, this paper focused
on a subset of ten genes extracted from the Kinase Panel
that were previously shown to be functionally important
speciﬁcally within the context of oocytes and seven func-
tionally dispensable genes.Criteria for Detection with the Use of NanoString
NanoString incorporates eight spiked-in negative control
probe sets that have no corresponding targets within the
sample and give a readout of background noise in the sys-
tem. By convention, a gene is considered to be detected if
its absolute count is higher than 2 standard deviations
above the mean count of the spiked-in negative control
samples (10). The detection threshold was calculated to be
23 in both of the assays undertaken in the present study.
We further considered that for detection the gene should
be above this threshold level in at least one sample from
every patient.Immunoblotting
Immunoblotting was performed as detailed previously
(13–16). In short, proteins were resolved on 4%–12%
Bis-Tris gels (Nupage; Invitrogen) before being transferred
to polyvinylidene diﬂuoride membranes (Millipore).
Membranes were blocked for 1 h at room temperature (RT)
in 3% bovine serum albumin (BSA; Sigma) before probing
with a sheep polyclonal anti-BubR1 primary antibody (a
kind gift from Professor Stephen Taylor, University of Man-
chester) overnight at 4C, followed by an horseradish perox-
idase–conjugated antisheep secondary antibody (Sigma) for
1 h at RT. Actin (Millipore) was used as a loading control.VOL. 101 NO. 3 / MARCH 2014Detection was performed with the use of ECL Plus (GE
Healthcare) ,and images were captured with the use of a
Chemidoc XRS Imaging System (Bio-Rad).Determination of Gene Functionality
We reasoned that those genes shown to be functionally
important in oocytes would be most informative regarding
oocyte quality.
CDK1 (for cyclin-dependent kinase 1) (17) and MOS (a
MAP kinase kinase kinase [or MAP3K] acting in a pathway
with MAP2K1) (18) are ﬁrmly established as universal and
well conserved regulators of mammalian oocyte maturation
and were obvious genes of interest. We identiﬁed seven addi-
tional genes from the Human Kinase Panel that have been
found to be important in mouse oocytes with the use of
gene-targeting strategies (Supplemental Table 3). These seven
genes included Aurora kinase A (AURKA) (19, 20), Aurora
kinase C (AURKC) (21, 22), BUB1 (23–25), BUB1B (15, 26,
27), CHEK1 (28, 29), FYN (30, 31), and WEE2 (or WEE1B)
(32, 33). Importantly, all of these genes are expressed in
human oocytes (1, 3, 5). Moreover, both AURKC (34) and
FYN (35) have also recently been studied at the protein level
in human oocytes.
We also identiﬁed six genes from the Human Kinase
Panel which, in contrast to the above functionally important
genes, have been shown to be functionally dispensable in
oocytes. Unlike the oocyte-speciﬁc WEE2 (32), there is a
distinct mitotic form known as WEE1 that is important in
somatic cells but dispensable in oocytes (33). In stark contrast
to CDK1, other CDKs, such as CDK2, CDK3, CDK4, and CDK6,
are dispensable for oocyte maturation (36). Unlike MOS,
another MAP3K, RAF1, does not play an important role in
the MAPK cascade in oocytes (37).
In summary therefore, we focused on ten functionally
important genes—AURKA, AURKC, BUB1, BUB1B, CDK1,
CHEK1, FYN, MAP2K1, MOS, andWEE2—and six function-
ally dispensable genes—CDK2, CDK3, CDK4, CDK6, RAF1,
and WEE1.Statistical Analyses
Statistical analyses were performed with the use of Graphpad
Instat software. A P value of< .05 with the use of the Student
t test was considered to be statistically signiﬁcant.
RESULTS
Detection of Multiple Transcripts in Single Human
Oocytes with the Use of NanoString
We found that transcripts for all ten functionally important
genes were detectable (Table 1). AURKA, BUB1B, CHEK1,
FYN, MAP2K1, MOS, and WEE2 were detected in all ten
MII-stage single-oocyte samples, AURKC and CDK1 were
detectable in nine of them, and BUB1 in eight (Table 1). Over-
all, therefore, 96 out of 100 reads exceeded the detection
threshold (Table 1).
We compared counts for the single-oocyte samples with
those for the 5-oocyte and 3-oocyte samples and found that
counts increased in relation to sample input for the functional859
TABLE 1
nCounter counts for single-oocyte samples.
1a 2 3 4 5
Empty Empty Empty GV GV P bMII MII MII MII MII MII MII MII MII MII
AURKA 295 309 328 276 328 378 391 254 357 240 1 2 0 475 484 .0004
AURKC 32 24 33 65 44 42 43 23c 36 32 1 2 1 35 57 .6416
BUB1 37 34 28 31 32 30 29 13c 52 18c 0 2 1 69 64 .0006
BUB1B 133 132 101 118 156 140 130 86 153 48 2 1 0 217 259 .0025
CDK1 58 80 65 56 92 64 83 46 111 23c 0 0 2 168 160 .0003
CHEK1 83 107 102 107 86 100 96 53 87 61 0 0 0 117 142 .0633
FYN 75 93 72 81 100 72 81 57 97 52 0 0 2 126 190 .0193
MAP2K1 295 282 231 325 243 291 268 188 275 214 1 1 0 460 449 .0044
MOS 46 69 71 105 81 93 82 36 63 28 1 1 4 171 220 .0066
WEE2 1,758 1,639 1,620 1,911 1,975 1,963 2,124 1,474 1,821 1,372 2 0 0 2,645 2,662 .0008
CDK2 3 2 2 1 2 1 0 2 2 0 0 0 0 4 4
CDK3 0 3 2 2 0 0 0 0 1 0 0 0 0 1 2
CDK4 4 3 3 5 2 3 3 2 2 2 1 2 0 6 6
CDK6 3 3 0 1 1 2 0 1 0 1 2 2 1 1 3
RAF1 1 0 1 1 0 0 1 1 0 0 0 0 0 2 1
WEE1 1 0 1 1 1 0 0 0 1 0 0 1 1 2 8
a Numbers above columns identify different patients.
b P values refer to statistical comparisons between counts in GV-stage (GV) oocytes and counts in MII-stage (MII) oocytes.
c Reads that do not exceed the detection threshold of 23.
Riris. Biomarkers of human oocyte quality. Fertil Steril 2014.
ORIGINAL ARTICLE: REPRODUCTIVE SCIENCEgenes (Supplemental Table 1). Indeed, further analysis of
WEE2, MAP2K1, and AURKA, the three kinases with the
highest counts, revealed a very high degree of correlation
(R > 0.96) between counts and sample input (Fig. 1).
In marked contrast to the ten functional genes, none of
the six dispensable genes—CDK2, CDK3, CDK4, CDK6,
RAF1, and WEE1—crossed the detection threshold in any of
the single-oocyte samples (Table 1). Furthermore, counts for
these six genes were similar to those found in empty samples
(Table 1) and remained undetectable in the 3- and 5-oocyte
samples (Supplemental Table 1).
Transcript abundance declines between the GV and MII
stages in both mouse (38) and human (3, 39) oocytes.
Entirely consistent with this, we found that transcript
abundance for eight of the ten functional genes was
signiﬁcantly higher at the GV stage than at the MII stage,
whereas all functionally dispensable genes remained
undetectable at all stages (Table 1).Variation in Transcript Abundance among
Individual Oocytes and Genes
We analyzed the counts of 3 oocytes we obtained from each of
two patients (patients 4 and 5; Table 1). Counts for the 10-
gene panel were on average higher in oocytes from patient
4 than in those from patient 5 (Table 2). Along with overall
higher counts for oocytes from patient 4, there was also
more oocyte-to-oocyte consistency, with no transcript exhib-
iting >1.5-fold difference in abundance from one oocyte to
the next (range 1.1–1.4-fold; Table 2). In stark contrast,
among oocytes from patient 5, counts for three genes
(BUB1, BUB1B, and CDK1) exhibited 3- to 5-fold differences,
and MOS varied by more than 2-fold (Table 2).
The marked variation in transcript abundance for patient
5 but not for patient 4 pointed to patient-speciﬁc variation
rather than inherent test instability. To examine this further,860we investigated ‘‘one-third’’ samples (three oocytes from a
third patient, patient 6, lysed together and divided into three
equal volumes), which were run on the same assay as oocytes
from patients 4 and 5 (Supplemental Table 2). Mean transcript
abundance for more than one-half of the genes in oocytes
from patient 6 were higher than those from either patient 4
or patient 5, again reafﬁrming interpatient differences
(Table 2). Notably, however, none of the genes in the
one-third samples showed >1.5-fold difference in counts
(Table 2), conﬁrming that patient 5’s oocyte-to-oocyte
variability did not reﬂect inherent assay properties.
We found wide variation in transcript abundance from
one gene to the next within individual oocytes. Thus, at the
high-abundance end of the spectrum wasWEE2, with counts
ranging from 1,474 to 2,124, roughly 6-fold higher than the
next most abundant kinase. In contrast, at the low end of
the range were genes such as BUB1 with counts from 13 to
52, roughly 50- to 100-fold lower than WEE2.Age-Related Changes in BubR1 Protein Levels
We observed a 1.5-fold reduction in mean BUB1B transcript
levels between a 39-year-old (patient 5) and a 31 year-old
(patient 4; Table 2). This is similar to the 1.42-fold reduction
observed previously between <32-year-olds and >40-year-
olds with the use of microarrays (40).We investigated whether
these changes in transcript abundance corresponded with
discernible changes in cognate protein levels by immunoblot-
ting ten oocytes from women %32 years old alongside ten
oocytes from women >37 years old. We found that the
BubR1 signal in the older age group was markedly reduced
compared with the younger age group, whereas the signal
for the actin loading control was indistinguishable (Fig. 2).
Thus, a1.5-fold transcript decline is associated with marked
reduction in protein expression.VOL. 101 NO. 3 / MARCH 2014
FIGURE 1
Correlation between counts for (A) WEE2, (B) MAP2K1, and (C)
AURKA and numbers of oocytes. R was used to calculate the
Pearson correlation coefﬁcient.
Riris. Biomarkers of human oocyte quality. Fertil Steril 2014.
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We used NanoString to investigate, for the ﬁrst time, human
oocytes and found that we could detect a panel of ten func-
tionally important genes in a single oocyte. This capability
was validated by data showing that counts were inextricably
linked with gene functionality (dispensable genes were uni-
formly undetectable), that counts correlated very strongly
with oocyte numbers, and that counts demonstrated predicted
changes regarding maturation stage. We also note that mean
AURKA, BUB1B, and CHEK1 counts were, respectively, 1.3-,
1.5-, and 1.4-fold lower for patient 5 (39 years old) than for
patient 4 (31 years old; Table 2) and that previous microarray
data showed 1.72-, 1.42-, and 1.35-fold decreases, respec-VOL. 101 NO. 3 / MARCH 2014tively, in these same transcripts between pooled oocytes
from young women (aged <32 years) and older women
(aged >40 years) (40). Therefore, although age-related
changes in transcript abundance was not a primary aim of
our study, it is nevertheless noteworthy that age-related
changes in counts we observed here are very similar inmagni-
tude to those reported previously for microarrays (40),
providing further validation for NanoString.
Strikingly, there was marked variation in transcript
abundance for key genes among oocytes from a given indi-
vidual. This new ﬁnding is distinct from the variations in
global gene expression proﬁles recently reported for individ-
ual oocytes from different patients (7). Also interesting was
the wide variation in relative transcript abundance within a
single oocyte. Genes such as BUB1 and AURKC are at one
extreme with counts per oocyte generally less than 50
whereas at the other extreme are genes such as WEE2 with
counts well above 1,000.
We wanted to determine whether the observed changes in
transcript abundance might be signiﬁcant enough to affect
gene function. We elected to examine BUB1B because previ-
ous microarray data for both humans (40) and mice (41),
along with the present NanoString results, indicated that
oocyte BUB1B transcripts consistently decline with age by
around 1.5-fold. We examined whether this degree of change
in BUB1B affected BubR1 protein levels by immunoblotting
oocytes from younger and older patients, and we found
marked reductions in BubR1 levels in older oocytes (Fig. 2).
This is highly signiﬁcant, because we and others previously
found that even modest reductions in BubR1 levels can
severely compromise BubR1 function and affect oocyte matu-
ration (15, 27). Interestingly, chromosome misalignment (42,
43) and missegregation (44) are prominent features of both
aged human oocytes and BubR1-depleted mouse oocytes
(15, 26, 27), suggesting that compromised BubR1 function
could be an important contributor to poor oocyte quality.
Given that 1.5-fold transcript reduction affected protein
expression, it is very possible that the 3- to 5-fold oocyte-
to-oocyte variation in transcript abundance that we observed
could have signiﬁcant implications for the function of a wider
range of genes. The defect incurred could be even greater still,
because BUB1B,BUB1, and CDK1 transcripts all exhibited re-
ductions within the same oocyte. Because all three are key
components of the SAC pathway, which is critical for pre-
venting aneuploidy (15, 23–27), the cumulative effect could
severely disrupt chromosome segregation ﬁdelity in that
oocyte.
The present report focused speciﬁcally on genes that have
been shown to be functional in the mouse oocyte model
(Supplemental Table 3). Although we acknowledge that the
functionality of most of these genes has not been corrobo-
rated directly in human oocytes, it must also be acknowledged
that this is impossible to achieve with the same level of rigor
as can be achieved with mouse oocytes owing to the extreme
dearth of biological material. Signiﬁcantly however, all of the
ten genes studied have been shown to be expressed in human
oocytes, and for some genes, such as AURKC and FYN, more
direct parallels have been drawn between mouse and human
oocytes (34, 35). Added to this, there is robust evidence that861
TABLE 2
Inter- and intrapatient variation in nCounter counts.
Single-oocyte samples
Ratio of means
One-third samples
Patient 4 (31 y) Patient 5 (39 y) Patient 6
Meana Fold changeb Meana Fold changeb Meana Fold changeb
AURKA 366 1.2 284 1.5 1.3 450 1.1
AURKC 43 1.1 30 1.6 1.4 73 1.5
BUB1 30 1.1 28 4.0 1.1 42 1.2
BUB1B 142 1.2 96 3.2 1.5 177 1.5
CDK1 79 1.4 60 4.9 1.3 118 1.3
CHEK1 94 1.2 67 1.7 1.4 105 1.1
FYN 84 1.4 69 1.9 1.2 130 1.3
MAP2K1 267 1.2 226 1.5 1.2 348 1.1
MOS 86 1.1 42 2.3 2.0 136 1.5
WEE2 2,020 1.1 1,556 1.3 1.3 2,188 1.1
a Mean of counts from the three samples analyzed per patient (see Table 1).
b Fold change between maximum and minimum counts obtained for each patient (see Table 1).
Riris. Biomarkers of human oocyte quality. Fertil Steril 2014.
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modulating CDK1 activity through WEE1 kinases (45) is
conserved between mouse and human oocytes (46).
Other emerging data further underscore the relevance of
the mouse model to understanding human oocyte regulation.
Thus, like women, female mice exhibit age-related fertility
decline linked to oocyte-derived aneuploidy and compro-
mised integrity of the molecular chromosomal ‘‘glue’’ known
as cohesin (47, 48). Other examples common to mouse and
human oocytes include the deacetylation of chromatin-
associated histones during maturation which is also vulner-FIGURE 2
Immunoblot of BubR1 and Actin in lysates of oocytes from young
(<32 years) and older (>37 years) women.
Riris. Biomarkers of human oocyte quality. Fertil Steril 2014.
862able to aging (49, 50) and the age-related accumulation of
oocyte DNA damage (51). Mouse and human oocytes also
show striking parallels regarding the proﬁle of transcripts
that become deregulated with age. In both sets of oocytes,
BUB1B and CHEK1 transcripts decline by similar magnitudes
(40, 41). Other examples of overlap include DNA repair genes,
such as BRCA1 (51), as well as the p53 family member TAp73
(52), which interestingly, has been shown to be an upstream
regulator of BubR1 in oocytes critical for female fertility
(53, 54).
Ethical considerations restricted us to using MII-stage
oocytes that had failed to fertilize. Although such oocytes
might not be considered to be representative of oocytes
that support fertilization, it does not detract from our ﬁnd-
ings that NanoString can proﬁle multiple transcripts in a
single human oocyte or that observed variations in tran-
script abundance are likely to be biologically meaningful.
It is important to note that the oocyte-to-oocyte heterogene-
ity we identiﬁed here pertains to a very uniform cohort of
oocytes: All failed to fertilize, all were derived from a single
patient and were therefore ‘‘internally’’ controlled regarding
their genetic and infertility background, and all were sub-
jected to identical culture conditions and sample prepara-
tion. This heterogeneity does not reﬂect inherent test
instability either, because it was not evident for all patients
and, importantly, it was not observed in the one-third sam-
ples. Based on these considerations, one might predict even
greater differences if comparisons were to be made between
the failed-to-fertilize cohort and oocytes that undergo fertil-
ization. Such differences, if indeed more marked, could be
clinically helpful for selecting the most developmentally
competent oocytes.
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